Crinetics Pharmaceuticals, Inc. (CRNX)
37.10
+0.82
(+2.27%)
USD |
NASDAQ |
May 21, 16:00
37.10
0.00 (0.00%)
After-Hours: 19:59
Crinetics Pharmaceuticals Research and Development Expense (TTM) : 351.77M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amneal Pharmaceuticals, Inc. | 185.93M |
| Aquestive Therapeutics, Inc. | 16.04M |
| Merck & Co., Inc. | 21.57B |
| Nektar Therapeutics | 122.50M |
| Prestige Consumer Healthcare, Inc. | -- |